Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 380590, 15 pages
http://dx.doi.org/10.1155/2015/380590
Research Article

Hypoxia-Inducible Factor 1 Is an Inductor of Transcription Factor Activating Protein 2 Epsilon Expression during Chondrogenic Differentiation

1Institute of Biochemistry, University of Erlangen-Nuremberg, Fahrstrasse 17, 91054 Erlangen, Germany
2Institute of Pathology, University of Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany
3Department of Trauma Surgery, University Hospital Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany

Received 15 February 2015; Revised 3 July 2015; Accepted 6 July 2015

Academic Editor: Martin Stoddart

Copyright © 2015 Stephan Niebler et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. V. Thorogood and J. R. Hinchliffe, “An analysis of the condensation process during chondrogenesis in the embryonic chick hind limb,” Journal of Embryology and Experimental Morphology, vol. 33, no. 3, pp. 581–606, 1975. View at Google Scholar · View at Scopus
  2. G. Karsenty and E. F. Wagner, “Reaching a genetic and molecular understanding of skeletal development,” Developmental Cell, vol. 2, no. 4, pp. 389–406, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. V. Lefebvre and P. Smits, “Transcriptional control of chondrocyte fate and differentiation,” Birth Defects Research Part C—Embryo Today, vol. 75, no. 3, pp. 200–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. B. Goldring, K. Tsuchimochi, and K. Ijiri, “The control of chondrogenesis,” Journal of Cellular Biochemistry, vol. 97, no. 1, pp. 33–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Karsenty, “Transcriptional control of skeletogenesis,” Annual Review of Genomics and Human Genetics, vol. 9, pp. 183–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Lefebvre and P. Bhattaram, “Vertebrate skeletogenesis,” Current Topics in Developmental Biology, vol. 90, pp. 291–317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. G. L. Wang, B.-H. Jiang, E. A. Rue, and G. L. Semenza, “Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 12, pp. 5510–5514, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Kallio, I. Pongratz, K. Gradin, J. McGuire, and L. Poellinger, “Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 11, pp. 5667–5672, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. P. J. Kallio, W. J. Wilson, S. O'Brien, Y. Makino, and L. Poellinger, “Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway,” The Journal of Biological Chemistry, vol. 274, no. 10, pp. 6519–6525, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. N. Masson and P. J. Ratcliffe, “HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels,” Journal of Cell Science, vol. 116, no. 15, pp. 3041–3049, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Q. Ke and M. Costa, “Hypoxia-inducible factor-1 (HIF-1),” Molecular Pharmacology, vol. 70, no. 5, pp. 1469–1480, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Schipani, “Hypoxia and HIF-1α in chondrogenesis,” Seminars in Cell and Developmental Biology, vol. 16, no. 4-5, pp. 539–546, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Amarilio, S. V. Viukov, A. Sharir, I. Eshkar-Oren, R. S. Johnson, and E. Zelzer, “HIF1α regulation of Sox9 in necessary to maintain differentiation of hypoxic prechondrogenic cells during early skeletogenesis,” Development, vol. 134, no. 21, pp. 3917–3928, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Schipani, H. E. Ryan, S. Didrickson, T. Kobayashi, M. Knight, and R. S. Johnson, “Hypoxia in cartilage: HIF-1α is essential for chondrocyte growth arrest and survival,” Genes & Development, vol. 15, no. 21, pp. 2865–2876, 2001. View at Google Scholar · View at Scopus
  15. A.-K. Wenke, S. Grässel, M. Moser, and A. K. Bosserhoff, “The cartilage-specific transcription factor Sox9 regulates AP-2ε expression in chondrocytes,” FEBS Journal, vol. 276, no. 9, pp. 2494–2504, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. A.-K. Wenke, T. Rothhammer, M. Moser, and A. K. Bosserhoff, “Regulation of integrin α10 expression in chondrocytes by the transcription factors AP-2ε and Ets-1,” Biochemical and Biophysical Research Communications, vol. 345, no. 1, pp. 495–501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Feng and T. Williams, “Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb,” Molecular and Cellular Neuroscience, vol. 24, no. 2, pp. 460–475, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Tummala, R.-A. Romano, E. Fuchs, and S. Sinha, “Molecular cloning and characterization of AP-2ε, a fifth member of the AP-2 family,” Gene, vol. 321, no. 1-2, pp. 93–102, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Hilger-Eversheim, M. Moser, H. Schorle, and R. Buettner, “Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control,” Gene, vol. 260, no. 1-2, pp. 1–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Huang, H. Xu, and L. Sandell, “Negative regulation of chondrocyte differentiation by transcription factor AP-2α,” Journal of Bone and Mineral Research, vol. 19, no. 2, pp. 245–255, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. A.-K. Wenke, S. Niebler, S. Grässel, and A. K. Bosserhoff, “The transcription factor AP-2ɛ regulates CXCL1 during cartilage development and in osteoarthritis,” Osteoarthritis and Cartilage, vol. 19, no. 2, pp. 206–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. D. Weston, V. Rosen, R. A. S. Chandraratna, and T. M. Underhill, “Regulation of skeletal progenitor differentiation by the BMP and retinoid signaling pathways,” The Journal of Cell Biology, vol. 148, no. 4, pp. 679–690, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. C. G. James, C. T. G. Appleton, V. Ulici, T. Michael Underhill, and F. Beier, “Microarray analyses of gene expression during chondrocyte differentiation identifies novel regulators of hypertrophy,” Molecular Biology of the Cell, vol. 16, no. 11, pp. 5316–5333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L.-A. Stanton and F. Beier, “Inhibition of p38 MAPK signaling in chondrocyte cultures results in enhanced osteogenic differentiation of perichondral cells,” Experimental Cell Research, vol. 313, no. 1, pp. 146–155, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Schmid, S. Schiffner, A. Opolka et al., “Enhanced cartilage regeneration in MIA/CD-RAP deficient mice,” Cell Death and Disease, vol. 1, article e97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Johnstone, T. M. Hering, A. I. Caplan, V. M. Goldberg, and J. U. Yoo, “In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells,” Experimental Cell Research, vol. 238, no. 1, pp. 265–272, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. J. U. Yoo, T. S. Barthel, K. Nishimura et al., “The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells,” The Journal of Bone and Joint Surgery—American Volume, vol. 80, no. 12, pp. 1745–1757, 1998. View at Google Scholar · View at Scopus
  28. P. Klinger, R. E. Schietke, C. Warnecke et al., “Deletion of the oxygen-dependent degradation domain results in impaired transcriptional activity of hypoxia-inducible factors,” Transcription, vol. 2, no. 6, pp. 269–275, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Murata, K. Yudo, H. Nakamura et al., “Hypoxia upregulates the expression of angiopoietin-like-4 in human articular chondrocytes: Role of angiopoietin-like-4 in the expression of matrix metalloproteinases and cartilage degradation,” Journal of Orthopaedic Research, vol. 27, no. 1, pp. 50–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Zhang, C. C. L. Wong, H. Wei et al., “HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs,” Oncogene, vol. 31, no. 14, pp. 1757–1770, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Zhu, Y. Y. Goh, H. F. A. Chin, S. Kersten, and N. S. Tan, “Angiopoietin-like 4: a decade of research,” Bioscience Reports, vol. 32, no. 3, pp. 211–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Wanek, K. Muneoka, G. Holler-Dinsmore, R. Burton, and S. V. Bryant, “A staging system for mouse limb development,” Journal of Experimental Zoology, vol. 249, no. 1, pp. 41–49, 1989. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Provot, D. Zinyk, Y. Gunes et al., “Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development,” The Journal of Cell Biology, vol. 177, no. 3, pp. 451–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Duval, S. Leclercq, J.-M. Elissalde, M. Demoor, P. Galéra, and K. Boumédiene, “Hypoxia-inducible factor 1α inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1α–dependent redifferentiation of chondrocytes,” Arthritis and Rheumatism, vol. 60, no. 10, pp. 3038–3048, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. C. Zhang, F. Yang, R. Cornelia, W. Tang, S. Swisher, and H. Kim, “Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis,” Bone, vol. 48, no. 3, pp. 507–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. A. M. Bhosale and J. B. Richardson, “Articular cartilage: structure, injuries and review of management,” British Medical Bulletin, vol. 87, no. 1, pp. 77–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Woo, T.-J. Lee, J.-W. Park, and T. K. Kwon, “Desferrioxamine, an iron chelator, enhances HIF-1α accumulation via cyclooxygenase-2 signaling pathway,” Biochemical and Biophysical Research Communications, vol. 343, no. 1, pp. 8–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. D. M. Bell, K. K. H. Leung, S. C. Wheatley et al., “SOX9 directly regulates the type-II collagen gene,” Nature Genetics, vol. 16, no. 2, pp. 174–178, 1997. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Lefebvre, W. Huang, V. R. Harley, P. N. Goodfellow, and B. de Crombrugghe, “SOX9 is a potent activator of the chondrocyte-specific enhancer of the proα1(II) collagen gene,” Molecular & Cellular Biology, vol. 17, no. 4, pp. 2336–2346, 1997. View at Google Scholar · View at Scopus
  40. W.-F. Xie, X. Zhang, S. Sakano, V. Lefebvre, and L. J. Sandell, “Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9,” Journal of Bone and Mineral Research, vol. 14, no. 5, pp. 757–763, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Yudoh, H. Nakamura, K. Masuko-Hongo, T. Kato, and K. Nishioka, “Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis,” Arthritis Research & Therapy, vol. 7, no. 4, pp. R904–R914, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Pfander and K. Gelse, “Hypoxia and osteoarthritis: how chondrocytes survive hypoxic environments,” Current Opinion in Rheumatology, vol. 19, no. 5, pp. 457–462, 2007. View at Publisher · View at Google Scholar · View at Scopus